Physician profile
Christopher C Schultz
NPI 1518394964
$2,185.27
in general payments reported to CMS, 2019-2025
13 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what 96% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.27 · 2020: $105 · 2021: $167 · 2022: $243 · 2023: $217 · 2024: $180 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022 · Education: $364 · Gift: $107 · Consulting Fee: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.79 |
| Education | $363.60 |
| Gift | $106.59 |
| Consulting Fee | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,419.45 | 2020-2025 | Invisalign, Maob, Itero |
| American Orthodontics Corporation | $274.74 | 2022-2025 | Lp and Ifit Tubes, Empower-Metal, Radiance |
| Envista Holdings Corporation | $140.98 | 2024-2025 | Insignia, Spark |
| 3m Company | $108.12 | 2019-2020 | |
| World Class Technology Corporation | $56.00 | 2022 | |
| Somnomed INC. | $52.94 | 2025 | |
| Gc America INC. | $27.48 | 2022 | |
| Lightforce Orthodontics, INC. | $26.83 | 2024 | |
| Straumann USA LLC | $22.00 | 2022 | |
| Kerr Corporation | $14.84 | 2021 | |
| Ortho Organizers, INC. | $14.69 | 2021 | |
| Nobel Biocare USA | $13.60 | 2023 | Nobelactive |
| Ormco Corporation | $13.60 | 2023 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.